Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Dr Tung'S Products Incorporated is active in the Biotechnology & Pharmaceuticals technology area with 1 pending office action currently under review. This action is being handled by a distinct examiner, MILLER, MAKENNA RYLEIGH. The involvement of 1 distinct art unit indicates that the company's pharmaceutical innovations are being evaluated within a single specialized group at the patent office.
The busiest examiner, MILLER, MAKENNA RYLEIGH, is managing 1 busiest examiner pending action. Because the portfolio only contains a pending office action and involves a distinct examiner, the prosecution is highly focused. The outcome for this portion of the portfolio depends on the specific requirements of the assigned examiner within the specified art unit. This centralized structure simplifies the management of the pending workload but places significant weight on the individual examiner's review. Successfully addressing the current office action will require a deep understanding of the specific examination patterns within the biotechnology sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MILLER, MAKENNA RYLEIGH | 1 | 100.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18649039 | TOOTHPOWDER COMPOSITION | MILLER, MAKENNA RYLEIGH | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18649039 | TOOTHPOWDER COMPOSITION | MILLER, MAKENNA RYLEIGH | 1611 | §101§103 | Final Rejection | — | Pending | Apr 29, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialDr Tung'S Products Incorporated has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Makenna Ryleigh Miller has the most, with 1 of Dr Tung'S Products Incorporated's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
